Search Results - Johan Vansteenkiste

Refine Results
  1. 1
    Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

    Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy by Johan Vansteenkiste

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The role of positron emission tomography with<sup>18</sup>F-fluoro-2-deoxy-D-glucose in respiratory oncology

    The role of positron emission tomography with<sup>18</sup>F-fluoro-2-deoxy-D-glucose in respiratory oncology by Johan Vansteenkiste, Sigrid Stroobants

    Published 2001
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Diagnostic tests of hyperventilation syndrome

    Diagnostic tests of hyperventilation syndrome by Johan Vansteenkiste, F Rochette, M. Demedts

    Published 1991
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Screening and early—detection of lung cancer

    Screening and early—detection of lung cancer by Johan Vansteenkiste, Christophe Dooms, Céline Mascaux, Kristiaan Nackaerts

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer

    The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer by Liesbet Schrevens, Natalie Lorent, Christophe Dooms, Johan Vansteenkiste

    Published 2004
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Capmatinib for the treatment of non-small cell lung cancer

    Capmatinib for the treatment of non-small cell lung cancer by Johan Vansteenkiste, C. Van De Kerkhove, Els Wauters, Pierre Van Mol

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study

    Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study by Johan Vansteenkiste, Sigrid Stroobants, Paul R. De Leyn, Patrick Dupont, Eric Verbeken

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography

    Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediasti... by Christophe Dooms, Eric Verbeken, Sigrid Stroobants, K. Nackaerts, Paul De Leyn, Johan Vansteenkiste

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Current status of immune checkpoint inhibition in early-stage NSCLC

    Current status of immune checkpoint inhibition in early-stage NSCLC by Johan Vansteenkiste, Els Wauters, Bart Reymen, Christoph Ackermann, Solange Peters, Dirk De Ruysscher

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

    Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer by R. Arriagada, Bengt Bergman, Ariane Dunant, Thierry Le Chevalier, Jean‐Pierre Pignon, Johan Vansteenkiste

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Johan Vansteenkiste, Dirk De Ruysscher, Wilfried Eberhardt, Eric Lim, Suresh Senan, Enriqueta Felip, Solange Peters

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases

    Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases by Johan Vansteenkiste, Paul R. De Leyn, Georges Deneffe, Georges Stalpaert, K. Nackaerts, Antoon Lerut, Maurits Demedts

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Lung cancer: Progress in diagnosis, staging and therapy

    Lung cancer: Progress in diagnosis, staging and therapy by Stephen Spiro, Nichole T. Tanner, Gerard A. Silvestri, Sam M. Janes, Eric Lim, Johan Vansteenkiste, Robert Pirker

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer

    Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer by Madelon Pijls-Johannesma, Dirk K.M. De Ruysscher, Philippe Lambin, Ruud Houben, I. Rutten, Johan Vansteenkiste

    Published 2004
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer

    Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer by Dirk De Ruysscher, Madelon Pijls-Johannesma, Johan Vansteenkiste, Arnold D.M. Kester, I. Rutten, Philippe Lambin

    Published 2005
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Association Between 18F-Fluoro-2-Deoxy-d-Glucose Uptake Values and Tumor Vitality: Prognostic Value of Positron Emission Tomography in Early-Stage Non-small Cell Lung Cancer

    Association Between 18F-Fluoro-2-Deoxy-d-Glucose Uptake Values and Tumor Vitality: Prognostic Value of Positron Emission Tomography in Early-Stage Non-small Cell Lung Cancer by Christophe Dooms, Angela van Baardwijk, Eric Verbeken, Robert Jan van Suylen, Sigrid Stroobants, Dirk De Ruysscher, Johan Vansteenkiste

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Survival after resection of synchronous bilateral lung cancer☆

    Survival after resection of synchronous bilateral lung cancer☆ by Paul De Leyn, Johnny Moons, Johan Vansteenkiste, Eric Verbeken, Dirk Van Raemdonck, Philippe Nafteux, Herbert Decaluwé, Antoon Lerut

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia

    Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Ind... by Heinz Ludwig, Jeffrey Crawford, Anders Österborg, Johan Vansteenkiste, David H. Henry, A. Fleishman, Ken Bridges, John A. Glaspy

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses

    Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses by Johan Vansteenkiste, John A. Glaspy, David H. Henry, Heinz Ludwig, Robert Pirker, Dianne Tomita, Helen Collins, Jeffrey Crawford

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Pieter E. Postmus, Keith M. Kerr, Matthijs Oudkerk, Suresh Senan, David Waller, Johan Vansteenkiste, Carles Escriu, Solange Peters

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: